To evaluate whether the selected YTHDF1 polymorphisms affect neuroblastoma risk among different subgroups, a stratified analysis was carried out according to age, sex, site of tumor origin, and clinical stage (Table 2). This evidence concerns the gene YTHDF1 and neoplasm.